018 Rejoice Trial: Evaluation of an Applicator-free Vaginal Estradiol Softgel Capsule for the Treatment of Postmenopausal Dyspareunia Associated with Vulvar and Vaginal Atrophy (VVA).
In: Journal of Sexual Medicine, Jg. 13 (2016-06-02), S. S246
academicJournal
Zugriff:
The article discusses research on the efficacy and safety of TX-004HR, an investigational applicator-free vaginal estradiol softgel capsule, for the treatment of postmenopausal dyspareunia associated with vulvar and vaginal atrophy (VVA) in postmenopausal women. The study evaluated patient outcome including vaginal superficial and parabasal cells, vaginal ion concentration (pH) and severity of dyspareunia in the treatment group in comparison to the placebo group.
Titel: |
018 Rejoice Trial: Evaluation of an Applicator-free Vaginal Estradiol Softgel Capsule for the Treatment of Postmenopausal Dyspareunia Associated with Vulvar and Vaginal Atrophy (VVA).
|
---|---|
Autor/in / Beteiligte Person: | Constantine, G. ; Bernick, B. ; Kushner, H. ; Mirkin, S. |
Zeitschrift: | Journal of Sexual Medicine, Jg. 13 (2016-06-02), S. S246 |
Veröffentlichung: | 2016 |
Medientyp: | academicJournal |
ISSN: | 1743-6095 (print) |
DOI: | 10.1016/j.jsxm.2016.04.018 |
Schlagwort: |
|
Sonstiges: |
|